SCHEMBL7991792

SCHEMBL7991792

Cc1cccc(Cn2cnc3[nH]c(-c4ccccn4)nc(=O)c32)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
METAP2 P50579 1/20 0.41
METAP1 P53582 1/20 0.41
CBFB Q13951 1/20 0.41
CNOT7 Q9UIV1 3/20 0.41
PARN O95453 1/20 0.41
HPGD P15428 3/20 0.41
TSHR P16473 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPC1 O15118 1/20 0.41
PKM P14618 1/20 0.41
RAB9A P51151 1/20 0.41
KRAS P01116 1/20 0.39
ALOX15 P16050 1/20 0.38
MMP13 P45452 1/20 0.38
IDO1 P14902 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991535 0.89 CNOT7 (0.43) ALDH1A1CYP11B1CYP11B2METAP2METAP1
SCHEMBL7985494 0.88 CNOT7 (0.52) ALDH1A1METAP2METAP1CNOT7PARN
SCHEMBL7992180 0.88 SMN1; SMN2 (0.45) METAP2METAP1CBFBCNOT7PARN
SCHEMBL7974009 0.88 METAP2 (0.41) METAP2METAP1CBFBCNOT7PARN
SCHEMBL7985461 0.87 TP53 (0.48) LMNANPC1RAB9ANPY5R
SCHEMBL7974270 0.86 ALDH1A1 (0.46) ALDH1A1CYP11B1CYP11B2CNOT7PARN
SCHEMBL7988751 0.84 CNOT7 (0.43) ALDH1A1CYP11B1CYP11B2CNOT7PARN
SCHEMBL7991785 0.84 HPGD (0.46) ALDH1A1CYP11B1CYP11B2METAP2METAP1
SCHEMBL7974312 0.83 HPGD (0.45) ALDH1A1CYP11B1CYP11B2CNOT7PARN
SCHEMBL7985238 0.82 LMNA (0.43) ALDH1A1CYP11B1CYP11B2CNOT7PARN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed